Electronic Tongue for Direct Assessment of SARS-CoV-2-Free and Infected Human Saliva-A Feasibility Study.

SARS-CoV-2 authentic human saliva differential pulse voltammetry electronic tongue principial component analysis

Journal

Biosensors
ISSN: 2079-6374
Titre abrégé: Biosensors (Basel)
Pays: Switzerland
ID NLM: 101609191

Informations de publication

Date de publication:
07 Jul 2023
Historique:
received: 12 05 2023
revised: 21 06 2023
accepted: 04 07 2023
medline: 31 7 2023
pubmed: 28 7 2023
entrez: 28 7 2023
Statut: epublish

Résumé

An electronic tongue is a powerful analytical instrument based on an array of non-selective chemical sensors with a partial specificity for data gathering and advanced pattern recognition methods for data analysis. Connecting electronic tongues with electrochemical techniques for data collection has led to various applications, mostly within sensing for food quality and environmental monitoring, but also in biomedical research for the analyses of different bioanalytes in human physiological fluids. In this paper, an electronic tongue consisting of six electrodes (viz., gold, platinum, palladium, titanium, iridium, and glassy carbon) was designed and tested in authentic (undiluted, unpretreated) human saliva samples from eight volunteers, collected before and during the COVID-19 pandemic. Investigations of 11 samples using differential pulse voltammetry and a principal component analysis allowed us to distinguish between SARS-CoV-2-free and infected authentic human saliva. This work, as a proof-of-principle demonstration, provides a new perspective for the use of electronic tongues in the field of enzyme-free electrochemical biosensing, highlighting their potential for future applications in non-invasive biomedical analyses.

Identifiants

pubmed: 37504115
pii: bios13070717
doi: 10.3390/bios13070717
pmc: PMC10377364
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : European Commission
ID : 813006
Organisme : Knowledge Foundation
ID : 20190010

Références

Philos Trans R Soc Lond B Biol Sci. 2011 Oct 27;366(1580):2936-41
pubmed: 21930585
Biomed Res Int. 2014;2014:962903
pubmed: 25276835
Diagnostics (Basel). 2017 Jul 04;7(3):
pubmed: 28677648
Mol Diagn Ther. 2009;13(4):245-59
pubmed: 19712004
Sens Actuators B Chem. 2022 Feb 15;353:131160
pubmed: 34866797
J Pharm Biomed Anal. 2020 Sep 5;188:113457
pubmed: 32663766
Clin Chim Acta. 2007 Aug;383(1-2):30-40
pubmed: 17512510
J Microbiol Immunol Infect. 2021 Apr;54(2):159-163
pubmed: 32265180
Chem Eng J. 2022 Feb 15;430:132966
pubmed: 34690533
Int J Mol Sci. 2022 Sep 03;23(17):
pubmed: 36077473
Gastro Hep Adv. 2022;1(2):194-209
pubmed: 35174369
Biosens Bioelectron. 2021 Mar 15;176:112905
pubmed: 33358285
Biosens Bioelectron. 2020 Oct 1;165:112454
pubmed: 32729549
Front Public Health. 2021 Nov 25;9:766871
pubmed: 34900912
Analyst. 2008 Oct;133(10):1440-8
pubmed: 18810293
MedComm (2020). 2023 Apr 08;4(2):e228
pubmed: 37041762
Analyst. 2004 Jul;129(7):639-44
pubmed: 15213833
J Dent Res. 2010 Oct;89(10):1016-23
pubmed: 20739693
Sensors (Basel). 2021 Nov 03;21(21):
pubmed: 34770617
Sci Rep. 2022 Jul 13;12(1):11867
pubmed: 35831456
Biosens Bioelectron. 2007 Apr 15;22(9-10):2171-8
pubmed: 17097867
Biosens Bioelectron. 2021 Apr 15;178:113029
pubmed: 33515985
Sensors (Basel). 2022 Sep 29;22(19):
pubmed: 36236521
Talanta. 2022 Aug 15;246:123537
pubmed: 35597231
Metabolomics. 2022 Oct 22;18(11):81
pubmed: 36271948
Sci Rep. 2016 Aug 25;6:32217
pubmed: 27558958
Front Bioeng Biotechnol. 2016 Oct 25;4:81
pubmed: 27826547
Bioelectrochemistry. 2022 Oct;147:108190
pubmed: 35738049
Biosensors (Basel). 2022 Jun 29;12(7):
pubmed: 35884276
Diagnostics (Basel). 2022 Jan 04;12(1):
pubmed: 35054277
Eur J Pharm Sci. 2017 Mar 1;99:266-271
pubmed: 28042103
J Infect. 2020 Jul;81(1):e45-e50
pubmed: 32298676
Biosensors (Basel). 2019 Feb 14;9(1):
pubmed: 30769890
Sci Rep. 2022 Jun 27;12(1):10879
pubmed: 35760827
Talanta. 2022 Jun 1;243:123327
pubmed: 35240367
Trends Biochem Sci. 2021 Dec;46(12):976-991
pubmed: 34511335
Metabolites. 2023 Feb 11;13(2):
pubmed: 36837882
Int J Mol Sci. 2022 Jan 08;23(2):
pubmed: 35054850

Auteurs

Magnus Falk (M)

Biomedical Science, Faculty of Health and Society, and Biofilms Research Center, Malmö University, 205 06 Malmö, Sweden.

Carolin Psotta (C)

Biomedical Science, Faculty of Health and Society, and Biofilms Research Center, Malmö University, 205 06 Malmö, Sweden.

Stefan Cirovic (S)

Biomedical Science, Faculty of Health and Society, and Biofilms Research Center, Malmö University, 205 06 Malmö, Sweden.

Lars Ohlsson (L)

Biomedical Science, Faculty of Health and Society, and Biofilms Research Center, Malmö University, 205 06 Malmö, Sweden.

Sergey Shleev (S)

Biomedical Science, Faculty of Health and Society, and Biofilms Research Center, Malmö University, 205 06 Malmö, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH